Analgesics (Pharmacies) - Senegal

Revenue in the Analgesics market is projected to reach US$10.83m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.57%, resulting in a market volume of US$15.60m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$0.59 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Senegal has been experiencing significant growth in recent years.

Customer preferences: Customers in Senegal have shown a strong preference for analgesics purchased from pharmacies. This preference can be attributed to the trust and reliability associated with purchasing medication from licensed pharmacies. Customers value the convenience and accessibility of pharmacies, as well as the expertise and advice provided by pharmacists.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in Senegal is the increasing demand for over-the-counter (OTC) analgesics. This trend can be attributed to several factors. Firstly, customers are becoming more proactive in managing their own health and are seeking immediate relief from common ailments such as headaches and muscle pain. Secondly, the rising healthcare costs and limited access to healthcare facilities in certain areas have led customers to rely on OTC analgesics as a cost-effective and accessible solution. Lastly, the growing awareness and availability of OTC analgesics in pharmacies have contributed to the increasing demand. Another trend in the market is the growing popularity of natural and herbal analgesics. This trend is driven by the increasing consumer awareness of the potential side effects and long-term health risks associated with traditional analgesics. Customers are seeking natural alternatives that are perceived to be safer and more sustainable. Pharmacies in Senegal have responded to this trend by expanding their range of natural and herbal analgesics to cater to the changing customer preferences.

Local special circumstances: Senegal is a country with a high burden of infectious diseases, such as malaria and dengue fever. This has led to a significant demand for analgesics to alleviate the symptoms associated with these diseases. Additionally, the country has a relatively young population, which is more prone to musculoskeletal pain and injuries. These local special circumstances contribute to the high demand for analgesics in Senegal.

Underlying macroeconomic factors: The growing middle class in Senegal, coupled with increasing disposable income, has contributed to the growth of the Analgesics (Pharmacies) market. As more individuals have the financial means to afford healthcare products, the demand for analgesics has increased. Furthermore, the government's efforts to improve healthcare infrastructure and access to medication have also played a role in driving the growth of the market. In conclusion, the Analgesics (Pharmacies) market in Senegal is experiencing significant growth due to customer preferences for purchasing medication from pharmacies, the increasing demand for OTC analgesics, the popularity of natural and herbal alternatives, local special circumstances such as the high burden of infectious diseases, and underlying macroeconomic factors such as the growing middle class and increasing disposable income.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.